- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 11.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 11.25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.78M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.77M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.38M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.92M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $16.78M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $21.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.78M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.5M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.78M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.5M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.06M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.8M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.22M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.04M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.30 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.68M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.51M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.72M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.26M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.33M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.54M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.41M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.77M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.16K |